N-Fmoc-O-cycloheptyl-N-methyl-L-serine carries a bulky cycloheptyl ether and N-methyl substitution that modify steric and hydrogen-bond characteristics. Researchers incorporate it to tune packing density and conformational rigidity. Its Fmoc protection supports SPPS inclusion. Applications include peptidomimetic design, rigidity engineering, and hydrophobic-surface modulation.
N-Fmoc-O-cycloheptyl-N-methyl-L-serine is a specialized amino acid derivative widely utilized in modern peptide synthesis and research. Featuring an Fmoc (9-fluorenylmethyloxycarbonyl) protecting group at the N-terminus, a cycloheptyl moiety on the serine side chain oxygen, and an N-methyl modification, this compound offers unique chemical and structural properties that enhance its utility in constructing complex peptide architectures. Its design enables improved control over peptide backbone conformation, side-chain orientation, and overall molecular stability, making it a valuable building block for researchers developing novel peptides with tailored functionalities. The presence of the cycloheptyl group contributes to increased hydrophobicity and steric bulk, which can influence folding patterns and resistance to enzymatic degradation. These features collectively position N-Fmoc-O-cycloheptyl-N-methyl-L-serine as a versatile tool in synthetic and structural peptide chemistry.
Peptide Design and Engineering: In the context of peptide design, N-Fmoc-O-cycloheptyl-N-methyl-L-serine serves as a critical monomer for introducing conformational constraints into peptide chains. Its bulky cycloheptyl group and N-methylation restrict the flexibility of the peptide backbone, promoting the formation of defined secondary structures such as helices or turns. This property is particularly advantageous for researchers aiming to stabilize bioactive conformations, enhance binding specificity, or mimic protein-like folds in short peptides. By incorporating this derivative into synthetic sequences, scientists can systematically study the effects of side-chain modifications on peptide folding and function, facilitating the rational design of peptides with improved biophysical and biochemical properties.
Peptidomimetic Development: The unique structure of Fmoc-O-cycloheptyl-N-methyl-L-serine makes it an ideal component in the creation of peptidomimetics—synthetic molecules that replicate the structure and function of natural peptides while offering enhanced stability and bioavailability. The cycloheptyl and N-methyl modifications confer resistance to enzymatic cleavage, addressing a common challenge in peptide-based research. When used in peptidomimetic synthesis, this compound allows for the exploration of new molecular scaffolds that retain biological activity but exhibit superior pharmacokinetic profiles. This application is especially relevant in the development of molecules intended for probing biological pathways, target validation, and the study of protein-protein interactions.
Solid-Phase Peptide Synthesis (SPPS): Fmoc-protected derivatives such as N-Fmoc-O-cycloheptyl-N-methyl-L-serine are integral to solid-phase peptide synthesis, a foundational technique for assembling custom peptides. Its compatibility with standard Fmoc SPPS protocols ensures efficient coupling and deprotection steps, even when constructing sequences with challenging modifications. The steric and electronic effects imparted by the cycloheptyl and N-methyl groups can reduce aggregation during synthesis and improve overall yields. Researchers leveraging SPPS can utilize this derivative to introduce site-specific modifications, study structure-activity relationships, or generate libraries of modified peptides for screening purposes.
Structure-Activity Relationship (SAR) Studies: The incorporation of N-Fmoc-O-cycloheptyl-N-methyl-L-serine into peptide sequences enables detailed investigation of structure-activity relationships. By systematically varying the position and frequency of this modified serine residue, scientists can assess how backbone rigidity, hydrophobicity, and steric hindrance influence biological interactions and functional outcomes. These insights are crucial for optimizing peptide leads, understanding molecular recognition processes, and guiding the design of next-generation peptide-based tools and probes.
Biophysical and Structural Analysis: The distinctive features of Fmoc-O-cycloheptyl-N-methyl-L-serine also support advanced biophysical and structural studies. Incorporating it into peptides allows researchers to probe folding dynamics, stability, and conformational preferences using techniques such as NMR spectroscopy, circular dichroism, or X-ray crystallography. The cycloheptyl group's steric bulk and the N-methylation's impact on hydrogen bonding patterns can be exploited to dissect the role of backbone and side-chain modifications in peptide architecture. Through these studies, the compound contributes to a deeper understanding of peptide chemistry and the factors governing molecular assembly and function.
1. Myotropic activity of allatostatins in tenebrionid beetles
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.